Related references
Note: Only part of the references are listed.What reinfections mean for COVID-19
Akiko Iwasaki
LANCET INFECTIOUS DISEASES (2021)
A global survey of potential acceptance of a COVID-19 vaccine
Jeffrey V. Lazarus et al.
NATURE MEDICINE (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang et al.
LANCET INFECTIOUS DISEASES (2021)
Updates on immunologic correlates of vaccine-induced protection
Stanley A. Plotkin
VACCINE (2020)
New immunization strategies: adapting to global challenges
Carsten Mantel et al.
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2020)
Ebola virus disease
Shevin T. Jacob et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
Paul-Henri Lambert et al.
VACCINE (2020)
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Eskild Petersen et al.
LANCET INFECTIOUS DISEASES (2020)
Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns
Raphael M. Zellweger et al.
EXPERT REVIEW OF VACCINES (2020)
Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
Amin Addetia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Seasonal coronavirus protective immunity is short-lasting
Arthur W. D. Edridge et al.
NATURE MEDICINE (2020)
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations
Philip R. Krause et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Bethany Dearlove et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines
Giuseppe Lofano et al.
NPJ VACCINES (2020)
More people are getting COVID-19 twice, suggesting immunity wanes quickly in some
Jop Vrieze
SCIENCE (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Challenges in estimating influenza vaccine effectiveness
Kylie E. C. Ainslie et al.
EXPERT REVIEW OF VACCINES (2019)
Assessing Vaccine Herd Protection by Killed Whole-Cell Oral Cholera Vaccines Using Different Study Designs
Mohammad Ali et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
Andrew Clark et al.
LANCET GLOBAL HEALTH (2019)
Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants A Systematic Review and Meta-analysis
Hai-Ling Lu et al.
JAMA NETWORK OPEN (2019)
Competing Effects of Indirect Protection and Clustering on the Power of Cluster-Randomized Controlled Vaccine Trials
Matt D. T. Hitchings et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
S. Sridhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Influenza vaccines: Evaluation of the safety profile
Claudia Maria Trombetta et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Choices in vaccine trial design in epidemics of emerging infections
Rebecca Kahn et al.
PLOS MEDICINE (2018)
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)
Ana Maria Henao-Restrepo et al.
LANCET (2017)
Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis
Qifang Bi et al.
LANCET INFECTIOUS DISEASES (2017)
The complexity and cost of vaccine manufacturing - An overview
Stanley Plotkin et al.
VACCINE (2017)
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls
Jennifer R. Verani et al.
VACCINE (2017)
The public health value of vaccines beyond efficacy: methods, measures and outcomes
A. Wilder-Smith et al.
BMC MEDICINE (2017)
Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy
Katsiaryna Holl et al.
BMC PUBLIC HEALTH (2016)
Fractional dosing of yellow fever vaccine to extend supply: a modelling study
Joseph T. Wu et al.
LANCET (2016)
Crude Vaccine Effectiveness Is a Misleading Term in Test-negative Studies of Influenza Vaccine Effectiveness
Sheena G. Sullivan et al.
EPIDEMIOLOGY (2015)
Modeling the Epidemiology of Cholera to Prevent Disease Transmission in Developing Countries
Zindoga Mukandavire et al.
MICROBIOLOGY SPECTRUM (2015)
Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program
Thomas J. Peto et al.
BMC INFECTIOUS DISEASES (2014)
Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices
S. Jadhav et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
The contribution of vaccination to global health: past, present and future
Brian Greenwood
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Correlates of protection to influenza virus, where do we go from here?
Rebecca J. Cox
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Nomenclature for Immune Correlates of Protection After Vaccination
Stanley A. Plotkin et al.
CLINICAL INFECTIOUS DISEASES (2012)
New Decade of Vaccines 3 Vaccine production, distribution, access, and uptake
Jon Smith et al.
LANCET (2011)
A Cluster-Randomized Effectiveness Trial of Vi Typhoid Vaccine in India
Dipika Sur et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial
Anna H. Roukens et al.
PLOS ONE (2008)
Controlling endemic cholera with oral vaccines
Ira M. Longini et al.
PLOS MEDICINE (2007)
Quality of the haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular Pertussis/Hib combination vaccines
Philippe A. Denoel et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Effectiveness of mass oral cholera vaccination in Beira, Mozambique
MES Lucas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Evolutionary and immunological implications of contemporary HIV-1 variation
B Korber et al.
BRITISH MEDICAL BULLETIN (2001)
Diphtheria toxoid vaccine effectiveness: A case-control study in Russia
KM Bisgard et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
